Priyanka Sharma

Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis o...

JAMA oncology · 1 februari 2026

A Fase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients...

Clinical cancer research : an official journal of the American Association for Cancer Research · 6 januari 2026

Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biom...

Clinical cancer research : an official journal of the American Association for Cancer Research · 3 november 2025

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the gerandomis...

Journal of the National Cancer Institute · 1 mei 2025

Endocriene therapie met of zonder everolimus als adjuvant bij mammacarcinoom: UNIRAD fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 september 2024

Fulvestrant-palbociclib-avelumab na CDK4/6-progressie bij mammacarcinoom: PACE fase II

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 juni 2024

PROs van adjuvant olaparib bij BRCA-gemuteerd mammacarcinoom: OlympiA analyse

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2024

RT-gebruik en locoregionaal recidief bij gunstig-risico klierpositief mammacarcinoom

JAMA oncology · 1 augustus 2023

SET-index en 21-genen score bij mammacarcinoom: vergelijking

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 april 2023

Cisplatine plus veliparib of placebo bij gemetastaseerd TNBC met BRCA-mutatie: S1416

The Lancet. Oncology · 2023-02

Biomarkers voor systemische therapie bij gemetastaseerd mammacarcinoom: ASCO 2022 richtlijn update

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 september 2022

21-genen assay en chemotherapievoordeel bij klierpositief mammacarcinoom: RxPONDER fase III

The New England journal of medicine · 16 december 2021

Anthracyclinevrij versus anthracycline-bevattend neoadjuvant carboplatine bij TNBC: fase II

Clinical cancer research : an official journal of the American Association for Cancer Research · 15 februari 2021